About us

Services

Contact

Carver College of Medicine Events

Women In Micro & Immuno Coffee Hour

Monday, January 13, 11:00am to Monday, December 8, 2025 12:00pm
Carver Biomedical Research Building
Join us for the Women in Micro & Immuno Coffee Hour. It is the monthly coffee hour on the second Monday of the month from 11 a.m. to noon in 1289 CBRB. Enjoy coffee, pastries and contribute to the discussion! This is open to ALL — students, staff, postdocs, and faculty interested in promoting women in science. Speakers change monthly. Contact: jessica-tucker@uiowa.edu for details.

Women In Micro & Immuno Coffee Hour

Monday, March 10, 2025 11:00am to Monday, February 2, 2026 11:00am
Carver Biomedical Research Building
Join us for the Women in Micro & Immuno Coffee Hour. It is the monthly coffee hour on the second Monday of the month from 11 a.m. to noon in 1289 CBRB. Enjoy coffee, pastries and contribute to the discussion! This is open to ALL — students, staff, postdocs, and faculty interested in promoting women in science. Speakers change monthly. Contact: jessica-tucker@uiowa.edu for details.

Internal Medicine Grand Rounds 3/20/2025

Thursday, March 20, 2025 12:00pm to 1:00pm
General Hospital
Canceled
Canceled

Clinical Conference: Glaucoma (Mansour F. Armaly Lecture)

Friday, March 21, 2025 8:00am to 12:00pm
Pomerantz Family Pavilion
8 a.m. to noon University of Iowa Health Care Pomerantz Family Pavilion Braley Auditorium | 01136 PFP Iowa City, IA Register Here!  The series of clinical conferences sponsored by the Department of Ophthalmology presents updated information on a broad spectrum of clinical issues and approaches that are of value and interest to the practicing ophthalmologist. General Information Individuals with disabilities are encouraged to attend all University of Iowa sponsored events. If you are a...

Clinical Conference: Glaucoma (Mansour F. Armaly Lecture)

Friday, March 21, 2025 8:00am to 12:00pm
Pomerantz Family Pavilion
8 a.m. to noon University of Iowa Health Care Pomerantz Family Pavilion Braley Auditorium | 01136 PFP Iowa City, IA Register Here! The series of clinical conferences sponsored by the Department of Ophthalmology presents updated information on a broad spectrum of clinical issues and approaches that are of value and interest to the practicing ophthalmologist. General Information Individuals with disabilities are encouraged to attend all University of Iowa sponsored events. If you are a...
View more events

Recent Articles from the University of Iowa

Evidence of Varicella Zoster Virus Reactivation in Children With Arterial Ischemic Stroke: Results of the VIPS II Study

Tuesday, March 18, 2025
Heather J Fullerton
CONCLUSIONS: One in 10 patients with childhood AIS had recent, asymptomatic VZV reactivation. In a vaccinated population, VZV may continue to play a modest role in childhood stroke pathogenesis.

Subacute Exposure of Male Adolescent Rats to 2,2',5,5'-Tetrachlorobiphenyl-4-ol via a Polymeric Implant Causes Gene Expression Changes in the Brain and Metabolomic Disruption in Serum

Monday, March 17, 2025
Hui Wang
Polychlorinated biphenyls (PCBs) remain an environmental health concern due to their persistence and ongoing release from legacy and emerging sources. 2,2',5,5'-Tetrachlorobiphenyl (PCB52), a PCB congener frequently detected in the environment and human blood, is oxidized to 2,2',5,5'-tetrachlorobiphenyl-4-ol (4-52). The neurotoxicity of this hydroxylated (OH-PCB) metabolite remains poorly characterized. In this study, we exposed 4-week-old male Sprague Dawley rats to 4-52 via a polymeric...

Innate Immunity and Asthma Exacerbations: Insights From Human Models

Saturday, March 15, 2025
Jehan Alladina
Asthma is a common chronic respiratory disease characterized by the presence of airway inflammation, airway hyperresponsiveness, and mucus hypersecretion. Repeated asthma exacerbations can lead to progressive airway remodeling and irreversible airflow obstruction. Thus, understanding and preventing asthma exacerbations are of paramount importance. Although multiple endotypes exist, asthma is most often driven by type 2 airway inflammation. New therapies that target specific type 2 mediators have...

CD3+ T-cell: CD14+ monocyte complexes are dynamic and increased with HIV and glucose intolerance

Wednesday, March 12, 2025
Laventa M Obare
Persistent systemic inflammation is associated with an elevated risk of cardiometabolic diseases. However, the characteristics of the innate and adaptive immune systems in individuals who develop these conditions remain poorly defined. Doublets, or cell-cell complexes, are routinely eliminated from flow cytometric and other immune phenotyping analyses, which limits our understanding of their relationship to disease states. Using well-characterized clinical cohorts, including participants with...

Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes

Tuesday, March 4, 2025
Albert Henry
Heart failure (HF) is a major contributor to global morbidity and mortality. While distinct clinical subtypes, defined by etiology and left ventricular ejection fraction, are well recognized, their genetic determinants remain inadequately understood. In this study, we report a genome-wide association study of HF and its subtypes in a sample of 1.9 million individuals. A total of 153,174 individuals had HF, of whom 44,012 had a nonischemic etiology (ni-HF). A subset of patients with ni-HF were...

Complement is primarily activated in the lung in a mouse model of severe COVID-19

Tuesday, March 4, 2025
Peter J Szachowicz
In vitro studies and observational human disease data suggest the complement system contributes to SARS-CoV-2 pathogenesis, although how complement dysregulation develops in severe COVID-19 is unknown. Here, using a mouse-adapted SARS-CoV-2 virus (SARS2-N501Y(MA30)) and a mouse model of COVID-19, we identify significant serologic and pulmonary complement activation post-infection. We observed C3 activation in airway and alveolar epithelia, and pulmonary vascular endothelia. Our evidence suggests...

Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025

Thursday, February 27, 2025
Ruth Link-Gelles
COVID-19 vaccination averted approximately 68,000 hospitalizations during the 2023-24 respiratory season. In June 2024, CDC and the Advisory Committee on Immunization Practices (ACIP) recommended that all persons aged ≥6 months receive a 2024-2025 COVID-19 vaccine, which targets Omicron JN.1 and JN.1-derived sublineages. Interim effectiveness of 2024-2025 COVID-19 vaccines was estimated against COVID-19-associated emergency department (ED) or urgent care (UC) visits during September 2024-January...

Severe acute respiratory syndrome coronavirus 2 infection unevenly impacts metabolism in the coronal periphery of the lungs

Tuesday, February 25, 2025
Jarrod Laro
SARS-CoV-2, the virus responsible for COVID-19, is a highly contagious virus that can lead to hospitalization and death. COVID-19 is characterized by its involvement in the lungs, particularly the lower lobes. To improve patient outcomes and treatment options, a better understanding of how SARS-CoV-2 impacts the body, particularly the lower respiratory system, is required. In this study, we sought to understand the spatial impact of COVID-19 on the lungs of mice infected with mouse-adapted...

The Cystic Fibrosis Transmembrane Conductance Receptor Brakes Allergic Airway Inflammation

Friday, February 21, 2025
Daniel P Cook
Cystic fibrosis (CF) is a common autosomal recessive disease resulting from mutations of the gene that encodes the cystic fibrosis transmembrane conductance regulator (CFTR). Although severe pulmonary neutrophilic inflammation is a primary pathologic feature of CF, more recent studies reveal a role for type 2 inflammation that is characterized by eosinophilia directed by both the innate and adaptive immune systems through ILC2 and CD4^(+) Th2 cells, respectively. We have published that a clear...

K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity

Wednesday, February 19, 2025
Qiuming Zeng
CONCLUSION: Nedd4 is a crucial E3 ubiquitin ligase for RORγt in the regulating Th17 cell development and offers potential therapeutic benefits for treating Th17-mediated autoimmune diseases.